Abstract:Cullin 4B (CUL4B) is a scaffold protein that assembles cullin-RING ubiquitin ligase (E3) complexes. Recent studies have revealed that germ-line mutations in CUL4B can cause mental retardation, short stature, and many other abnormalities in humans. Identifying specific CUL4B substrates will help to better understand the physiological functions of CUL4B. Here, we report the identification of peroxiredoxin III (PrxIII) as a novel substrate of the CUL4B ubiquitin ligase complex. Two-dimensional gel electrophoresis coupled with mass spectrometry showed that PrxIII was among the proteins up-regulated in cells after RNAi-mediated CUL4B depletion. The impaired degradation of PrxIII observed in CUL4B knockdown cells was confirmed by Western blot. We further demonstrated that DDB1 and ROC1 in the DDB1-CUL4B-ROC1 complex are also indispensable for the proteolysis of PrxIII. In addition, the degradation of PrxIII is independent of CUL4A, a cullin family member closely related to CUL4B. In vitro and in vivo ubiquitination assays revealed that CUL4B promoted the polyubiquitination of PrxIII. Furthermore, we observed a significant decrease in cellular reactive oxygen species (ROS) production in CUL4B-silenced cells, which was associated with increased resistance to hypoxia and H(2)O(2)-induced apoptosis. These findings are discussed with regard to the known function of PrxIII as a ROS scavenger and the high endogenous ROS levels required for neural stem cell proliferation. Together, our study has identified a specific target substrate of CUL4B ubiquitin ligase that may have significant implications for the pathogenesis observed in patients with mutations in CUL4B.

CRL4BRBBP7 Targets HUWE1 for Ubiquitination and Proteasomal Degradation.

DNA damage-induced activation of CUL4B targets HUWE1 for proteasomal degradation.

The Functions and Properties of Cullin-5, a Potential Therapeutic Target for Cancers.

SIRT7 deacetylates DDB1 and suppresses the activity of the CRL4 E3 ligase complexes.

HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.

HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin–proteasome pathway (Biochemical and Biophysical Research Communications, v. 444, isse 4)

Targeted Polyubiquitylation of RASSF1C by the Mule and SCFβ-TrCP Ligases in Response to DNA Damage

CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability

Mule/ARF-BP1, a BH3-Only E3 Ubiquitin Ligase, Catalyzes the Polyubiquitination of Mcl-1 and Regulates Apoptosis

CUL4–DDB1 Ubiquitin Ligase Interacts with Multiple WD40-repeat Proteins and Regulates Histone Methylation

Histone Ubiquitination Associates With Brca1-Dependent Dna Damage Response

CRL4B catalyzes H2AK119 monoubiquitination and coordinates with PRC2 to promote tumorigenesis.

A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.

CRL4-DCAF8L2 E3 Ligase Promotes Ubiquitination and Degradation of BARD1

USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response

UBE2G1 governs the destruction of cereblon neomorphic substrates.

Cullin 4B Protein Ubiquitin Ligase Targets Peroxiredoxin III for Degradation

Dna Damage Regulates Uhrf1 Stability Via The Scf Beta-Trcp E3 Ligase

Pathogenic Roles of the Cullin E3 Ligase Scaffolding Protein CUL4B

CRL4B Interacts with and Coordinates the SIN3A-HDAC Complex to Repress CDKN1A and Drive Cell Cycle Progression

X-linked Intellectual Disability Gene CUL4B Targets Jab1/CSN5 for Degradation and Regulates Bone Morphogenetic Protein Signaling.